Exemplis Discimus 2001, 145(2):27-38

Vivamus semper ornare quam.

Tersen Zamba
Department of Parasitology, Coruscant University Hospital, Republic of Taanab

Praesent eleifend, sem eget consectetuer fermentum, dolor urna cursus felis, ac viverra nulla metus ut tortor. Phasellus convallis, dolor sed mollis pharetra, tortor ipsum pulvinar sem, eu sollicitudin eros erat non purus.

Keywords: Curabitur sem, Sed ac erat, Duis mi, Proin in metus

Published: December 1, 2001 

Open full article

References

  1. Serlin, M. J., Breckenridge, A. M. (1983) Drug interactions with warfarin. Drugs, 25, 610-620. Go to original source... Go to PubMed...
  2. Brozovic, M. (1976) Oral anticoagulants, vitamin K and prothrombin complex factors. British Journal of Heamatology; 32, 9-12. Go to original source... Go to PubMed...
  3. Suttie, J. W., Grant, G. A., Esmon, C. T., Shah, D. V. (1974) Postribosomal function of vitamin K1 in prothrombin synthesis. Mayo Clinic Proceedings; 49, 933-940. Go to PubMed...
  4. USPDI - Drug Information for the Health Care Professionals, 18th ed., vol. 1, The United States Pharmacopoeial Convention, Inc, Rockville, 1998, 3363 p.
  5. Magid, E. (1962) Tolerance to anticoagulants during antibiotic therapy. Scandinavian Journal of Clinical and Laboratory Investigation; 14, 565-566. Go to original source...
  6. Udall, J. A. (1965) Human sources and absorption of vitamin K in relation to anticoagulation stability. Journal of the American Medical Association; 194, 127-129. Go to original source... Go to PubMed...
  7. OReilly, R. A., Aggeler, P. M. (1970) Determinants of the response to oral anticoagulant drugs in man. Pharmacol. Rev.; 22, 35-96. Go to PubMed...
  8. Kippel, A. P., Pitsinger, B. (1968) Hypoprothrombinemia secondary to antibiotic therapy and manifested by gastrointestinal hemorrhage: report of three cases. Arch. Surg.; 96, 266. Go to original source... Go to PubMed...
  9. Christensen, L. K., Skovsted, L. (1969) Inhibition of drug metabolism by chloramphenicol. Lancet; 2, 1397. Go to original source... Go to PubMed...
  10. Ansell, J. E., Kumar, R., Deykin, D. (1977) The spectrum of vitamin K deficiency. JAMA; 238, 40-42. Go to original source... Go to PubMed...
  11. Yacobi, A., Lai, C. M., Levy, G. (1984) Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats. J. Pharmacol. Exp. Ther.; 231, 80-84. Go to PubMed...
  12. Martindale - The Complete Drug Reference, 33rd ed.. London: Pharmaceutical Press. 1999; 2315
  13. Angaran, D. M. et al (1984) The influence of prophylactic antibiotics on the warfarin anticoagulation response in the postoperative prosthetic cardiac valve patient. Ann. Sur., 1984; 199, 107-111. Go to original source... Go to PubMed...
  14. Angaran, D. M. et al (1984) The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patients: cefamandole, cefazoline, vancomycin. Ann. Sur.; 1987, 206, 155-161. Go to original source... Go to PubMed...
  15. Hansten, P. D. Drug Interactions, 4th ed., Philadelphia: Lea and Febiger 1979.
  16. Becker, G. L. (1952) The case against mineral oil. Am. J. Dig. Dis.; 19, 344. Go to original source... Go to PubMed...
  17. Morowitz, D. A. (1968) Complications of long-term mineral oil intake. JAMA; 204, 937.
  18. Koch-Weser, J., Sellers, E. M. (1971) Drug Interactions with Coumarin Anticoagulants. New England Journal of Medicine; 285, 487-498, 547-558. Go to original source...
  19. Koch-Weser, J. (1973) Hemorrhagic reactions and drug interactions in 500 warfarin-treated patients. Clin. Pharmacol. Ther.; 14, 139.
  20. Jahnchen, E., Meinertz, T., Gilfrich, H. J. et al. (1978) Enhanced elimination of warfarin during treatment with cholestyramine. Br. J. Clin. Pharmacol.; 5, 437-440. Go to original source... Go to PubMed...
  21. Hunninghake, D. B., Pollack, E. (1977) Effect of bile acid sequestering agents on the absorption of aspirin, tolbutamide, and warfarin. Fed. Proc.; 36, 996.
  22. Schrogie, J. J., Solomon, H. M., Zieve, P. D. (1967) Effect of Oral Contraceptives on Vitamin K-dependent Clotting Activity. Clinical Pharmacology and Therapeutics; 8, 670-675. Go to PubMed...
  23. Therapeutic drugs. 2nd ed by CT. Dollery. 2nd , vol. 2, Edinburgh: Churchill Livingstone, 1999.
  24. Devor, M., Barrett-Connor, E., Renvall, M. et al. (1992) Estrogen replacement therapy and the risk of venous thrombosis. Am. J. Med.; 92, 275-282. Go to original source... Go to PubMed...
  25. Robinson, B. H., Hawkins, J. B., Ellis, J. E. et al. (1971) Decreased anticoagulant tolerance with oxymetholone. Lancet; 1, 1356. Go to original source...
  26. Longridge, R. G., Gillam, P. M., Barton, G. M. (1971) Decreased anticoagulant tolerance with oxymetholone. Lancet; 2, 90. Go to original source...
  27. Edwards, M. S., Curtis, J. R. (1971) Decreased anticoagulant tolerance with oxymetholone. Lancet; 2, 221. Go to original source...
  28. Acomb, C., Shaw, P. W. (1985) A significant interaction between warfarin and stanozolol. Pharm. J.; 234, 73-74.
  29. Shaw, P. W., Smith, A. M. (1987) Possible interaction of warfarin and stanozolol. Clin. Pharm.; 6, 500-502. Go to PubMed...
  30. Goulbourne, I. A., Macleod, D. A. (1981) An interaction between danazol and warfarin. Case report. Br. J. Obstet. Gynaecol; 88, 950-951. Go to original source...
  31. Meeks, M. L., Mahaffey, K. W., Katz, M. D. (1992) Danazol increases the anticoagulant effect of warfarin. Ann. Pharmacother.; 26, 641-642. Go to PubMed...
  32. Booth, C. D. (1993) A drug interaction between danazol and warfarin. Ann. Pharmacother.; 250, 439-440.
  33. Schrogie, J. J., Solomon, H. M. (1967) The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone. Clin. Pharmacol. Ther.; 8, 70-77. Go to PubMed...
  34. Lorentz, S. M., Weibert, R. T. (1985) Potentiation of warfarin anticoagulation by topical testosterone ointment. Clin. Pharm.; 4, 332-334. Go to PubMed...
  35. OReilly, R. A. (1980) Spironolactone and Warfarin Interaction. Clinical Pharmacology and Therapeutics; 27, 198-201. Go to original source... Go to PubMed...
  36. OReilly, R. A., Sahud, M. A., Aggeler, P. M. (1971) Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulant drugs in man. Ann. NY. Acad. Sci.; 179, 173-183. Go to original source... Go to PubMed...
  37. OReilly, R. A., Sahud, M. A., Robinson, A. J. (1972) Studies on the interaction of warfarin and clofibrate in man. Thrombosis et Diathesis Haemorrhagica; 27, 309-318. Go to PubMed...
  38. Custer, G. M., Briggs, B. R., Smith, R. E. (1979) Effect of cefamandole nafate on blood coagulation and platelet function. Antimicrob. Agents Chemother.; 16, 869-872. Go to original source... Go to PubMed...
  39. Fainstein, V., Bodey, G. P., McCredie, K. B. et al. (1983) Coagulation abnormalities induced by beta-lactam antibiotics in cancer patients. J. Infect. Dis.; 148, 745-750. Go to original source... Go to PubMed...
  40. Osborne, J. C. (1985) Hypoprothrombinemia and bleeding due to cefoperazone. Ann. Intern. Med.; 102, 721-722. Go to original source...
  41. Cristiano, P. (1984) Hypoprothrombinemia associated with cefoperazone treatment. Drug Intell. Clin. Pharm.; 18, 314-316. Go to PubMed...
  42. Bjornsson, T. D., Meffin, P. J., Swezey, S. E. et al. (1979) Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1. J. Pharmacol. Exp. Ther.; 210, 322-326. Go to PubMed...
  43. Owens, J. C. et al. (1962) Effect of sodium dextrothyroxine in patients receiving anticoagulants. N. Engl. J. Med.; 266, 76-79. Go to original source... Go to PubMed...
  44. Solomon H. M., Schrogie J. J. (1967) Change in receptor site affinity: a proposed explanation fo the potentiating effect of D-thyroxine on the anticoagulant response to warfarin. Clin. Pharmacol. Ther.; 8, 797-799. Go to PubMed...
  45. Hansten, P. D. (1980) Oral anticoagulants and drugs which alter thyroid function. Drug Intell. Clin. Pharm.; 14, 331-334.
  46. Veganakis, A. G., Cote, R., Miller, M. E. et al. (1972) Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis. Johns Hopkins Med. J.; 131, 69-73. Go to PubMed...
  47. Guthrie, S. K. et al. (1995) Hypothesized interaction between valproic acid and warfarin. J. Clin. Psychopharmacol.; 15, 138-139. Go to original source... Go to PubMed...
  48. Clark, D. J. (1983) Critical crucio: warfarin and tonic water. Br. Med. J.; 283, 1258.
  49. Seifter, E. J., Brooks, B. J. J., Urba, W. J. (1985) Possible interactions between warfarin and antineoplastic drugs. Cancer Treat. Rep.; 69, 244-245. Go to PubMed...
  50. Tashima, C. K. (1979) Cyclophophamide effect on coumarin anticoagulation. South Med. J.; 72, 633-634. Go to original source... Go to PubMed...
  51. Spiers, A. S., Mibashan, R. S. (1974) Increased warfarin requirement during mercaptopurine therapy: a new drug interaction. Lancet; 2, 221. Go to original source... Go to PubMed...
  52. Singleton, J. D., Conyers, L. (1992) Warfarin and azathioprine: an important drug interaction. Am. J. Med.; 92, 217. Go to original source...
  53. Martini, A., Jahnchen, E. (1977) Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin. J. Pharmacol. Exp. Ther.; 201, 547-553. Go to PubMed...
  54. Haworth, E., Burroughs, A. K. (1977) Disopyramide and warfarin interaction. Br. Med. J.; 2, 866-867. Go to original source... Go to PubMed...
  55. Gazzaniga, A. B., Stewart, D. R. (1969) Possible quinidineinduced hemorrhage in a patient on warfarin sodium. N. Engl. J. Med.; 280, 711-712. Go to original source... Go to PubMed...
  56. Sylven, C., Anderson, P. (1983) Evidence that disopyramide does not interact with warfarin. Br. Med. J.; 286, 1181. Go to original source...
  57. Jones, F. L. J. (1968) More on quinidine-induced hypoprothrombinemia. Ann. Intern. Med.; 69, 1074. Go to original source...
  58. OReilly, R. A. (1981) Lack of effect of fortified wine ingested during fasting and anticoagulant therapy. Arch. Intern. Med.; 141, 458-459. Go to original source... Go to PubMed...
  59. Koch-Weser, J. (1970) Potentiation by glucagon of the hypoprothrombinemic action of warfarin. Ann. Intern. Med.; 72, 331-335. Go to original source... Go to PubMed...
  60. Roth, G. J., Majerus, P. W. (1975) The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. Journal of Clinical Investigation; 56, 624-632. Go to original source... Go to PubMed...
  61. Roth, G. J., Stanford, N., Majerus, P. W. (1975) Acetylation of prostaglandin synthetase by aspirin. Proceedings of the National Academy of Science; 72, 3073-3076. Go to original source...
  62. Quick, A. J., Clesceri, L. (1960) Influence of acetylosalicylic acid and salicylamide on the coagulation of blood. Journal of Pharmacology and Experimental Therapeutics; 128, 95-98. Go to PubMed...
  63. Chan, T. Y. K. (1995) Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance. Ann. Pharmacother.; 29, 1274-1283. Go to PubMed...
  64. OReilly, R. A. (1987) Warfarin metabolism and drug-drug interactions. Advances in Experimental Medicine & Biology; 214, 205-212.
  65. Estes, D., Kaplan, K. (1980) Lack of platelet effect with the aspirin analog, salsalate. Arthritis Rheum.; 23, 1303-1307. Go to original source... Go to PubMed...
  66. Roth, S. H. (1988) Salicylates revisited. Are they still the hallmark of anti-inflammatory therapy? Drugs; 36, 1-6. Go to original source...
  67. Brown, Ch., Natelson, E. A., Bradshaw, M. W. (1975) Study of the effect of ticarcillin on blood coagulation and platelet function. Antimicrobial Agents and Chemotherapy; 7, 652-657. Go to original source... Go to PubMed...
  68. Vesell, E. S., Passananti, G. T., Johnson, A. O. (1975) Failure of indomethacin and warfarin to interact in normal human volunteers. J. Clin. Pharmacol. 1975; 15, 486-495. Go to original source...
  69. Self, T. H., Evans, W. E., Ferguson, T. (1975) Drug enhancement of warfarin activity. Lancet; 2, 557-558. Go to original source...
  70. Pullar, T., Capell, H. A. (1982) Interaction of indomethacin and warfarin. Br. Med. J. Clin. Res.; 284, 198. Go to original source...
  71. Stricker, B. H., Delhez, J. L. (1982) Interactions between flurbiprofen and coumarins. Br. Med. J.; 285, 812-813. Go to original source...
  72. Barager, F. D., Smith, T. C. (1978) Drug interaction studies with sodium meclofenamate (Meclomen(R)). Curr. Ther. Res.; 23, 51.
  73. Diana, F. J., Veronich, K., Kapoor, A. L. (1989) Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin. J. Pharm. Sci.; 78, 195-199. Go to original source... Go to PubMed...
  74. Holmes, E. L. (1966) Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects. Ann. Phys. Med.; 9(suppl), 36-49.
  75. Rhodes, R. S., Rhodes, P. J., Klein, C. et al. (1985) A warfarinpiroxicam drug interaction. Drug Intell. Clin. Pharm.; 19, 556-558. Go to PubMed...
  76. Carter, S. A. (1979) Potential effect of sulindac on response of prothrombin-time to oral anticoagulants. Lancet; 2, 698-699. Go to original source...
  77. Ross, J. R., Beeley, L. (1979) Sulindac, prothrombin time, and anticoagulants. Lancet; 2, 1075. Go to original source...
  78. Whittaker, S. J. et al. (1986) A severe, potentially fatal, interaction between tiaprofenic acid and nicoumalone. Br. J. Clin. Pract.; 40, 440. Go to PubMed...
  79. Koren, J. F., Cochran, D. L., Janes, R. L. (1987) Tolmetinwarfarin interaction. Am. J. Med.; 82, 1278-1280. Go to original source...
  80. Ermer, J. C., Hicks, D. R., Wheeler, S. C. et al. (1994) Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarin. Clin. Pharmacol. Ther.; 55, 305-316. Go to original source... Go to PubMed...
  81. Penner, J. A., Abbrecht, P. H. (1975) Lack of interaction between ibuprofen and warfarin. Curr. Ther. Res.; 18, 862-871. Go to PubMed...
  82. Jain, A., McMahon, F. H., Slattery, J. T. et al. (1979) Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin. Clin. Pharmacol. Ther.; 25, 61-66. Go to PubMed...
  83. Apseloff, G., Wilner, K. D., Gerber, N. (1995) Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers. Br. J. Clin. Pharmacol.; 39, 29S-33S. Go to original source...
  84. Kates, R. E., Yee, Y. G., Kirsten, E. B. (1987): Interaction between warfarin and propafenone in healthy volunteer subjects. Clin. Pharmacol. Ther.; 42, 305-311. Go to original source... Go to PubMed...
  85. Levine, M. N. et al. (1989) Hemorrhagic complications of longterm anticoagulant therapy. Chest; 95, 26S-36S. Go to original source...
  86. Chow, W. H., Cheung, K. L., Ling, H. M. et al. (1989) Potentiation of warfarin anticoagulation by topical methylsalicylate ointment. J. R. Soc. Med.; 82, 501-502. Go to PubMed...
  87. Spigset, O. (1994) Reduced effect of warfarin caused by ubidecarenone. Lancet; 344, 1372-1373. Go to original source... Go to PubMed...
  88. McElnay, J. C. et al. (1978) Interaction of warfarin with antacid constituents. Br. Med. J.; 2, 1166. Go to original source...
  89. Ambre, J. J., Fischer, L. J. (1973) Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man. Clin. Pharmacol. Ther.; 14, 231-237. Go to PubMed...
  90. Mungall, D., Talbert, R. L., Phillips, C. et al. (1983) Sucralfate and warfarin. Ann. Intern. Med.; 98, 557. Go to original source...
  91. Braverman, S. E., Marino, M. T. (1988) Sucralfate-warfarin interaction. Drug. Intell. Clin. Pharm.; 22, 913.
  92. Rey, A. M., Gums, J. G. (1991) Altered absorption of digoxin, sustained-released quinidine, and warfarin with sucralfate administration. DICP; 25, 745-746. Go to PubMed...
  93. Darlington, M. R. (1997) Hypoprothrombinemia induced by warfarin sodium and cisapride. Ann. Pharmacother.; 54, 320.
  94. Marinella, M. A. (1998) Mesalamine and warfarin therapy resulting in decreased warfarin effect. Ann. Pharmacother.; 32, 841-842. Go to original source...
  95. Morreale, A. P., Janetzky, K. (1997) Probable interaction of warfarin and acarbose. Am. J. Health Syst Pharm.; 54, 1551-1552. Go to PubMed...
  96. Banfield, C., OReilly, R., Chan, E. et al. (1983) Phenylbutazone- warfarin interaction in man: further stereochemical and metabolic considerations. Br. J. Clin. Pharmacol.; 16, 669-675. Go to original source... Go to PubMed...
  97. Brouwers, J. R., de Smet, P. A. (1994) Pharmacokinetic-pharmacodynamice drug interactions with nonsteroidal anti-inflammatory drugs. Clin. Pharmacokinet.; 27, 462-485. Go to original source... Go to PubMed...
  98. Serlin, M. J., Mossman, S., Sibeon, R. G. et al. (1980) Interaction between diflunisal and warfarin. Clin. Pharmacol. Ther.; 28, 493-498. Go to original source... Go to PubMed...
  99. Schulman, S., Henriksson, K. (1989) Interaction of ibuprofen and warfarin on primary haemostasis. Br. J. Rheumatol.; 28, 46-49. Go to original source...
  100. Hoffbrand, B. I. (1987) Interaction of nalidixic acid and warfarin. Br. Med. J.; 2, 666. Go to original source...
  101. Leor, J., Levartowsky, D., Sharon, C. (1987) Interaction between nalidixic acid and warfarin. Ann. Intern. Med.; 107, 601. Go to original source...
  102. Potasman, I., Bassan. H. (1980) Nicoumalone and nalidixic acid interactions. Ann. Intern. Med.; 92, 571. Go to original source...
  103. Jassal, S. V. (1991) Warfarin potentiated by proguanil. Br. Med. J., 303, 300.
  104. Hamblin, T. J. (1971) Interaction between warfarin and phenphormin. Lancet, 11, 1323. Go to original source...
  105. Kristensen, M., Hansen, J. M. (1967) Potentiation of the tolbutamide effect by dicumarol. Diabetes; 16, 211-214. Go to original source... Go to PubMed...
  106. Hicks, R., Dysken, M. W., Davis, J. M. et al. (1981) The pharmacokinetics of psychotropic medication in the elderly: a review. J. Clin. Psychiatry; 42, 374-385. Go to PubMed...
  107. Udall, J. A. (1975) Clinical implications of warfarin interactions with five sedatives. Am. J. Cardiol.; 35, 67-71. Go to original source... Go to PubMed...
  108. Sellers, E. M., Koch-Weser, J. (1971) Kinetics and clinical importance of displacement of warfarin from human albumin by acidic drugs. Ann. N. J. Med.; 179, 213-225. Go to original source...
  109. Ellison, J., Thomson, A., Greer, I. (2000) Apparent interaction between warfarin and levonorgestrel used for emergency contraception. B.M.J.; 321,1382. Go to original source... Go to PubMed...
  110. Herve, F., Duche, J. C., d Athis, P. et al. Binding of disopyramine, methodone, dipyridamole, chlorpromazine, lignicaine and progesterone to the two main genetic variats and for the separate drug-binding sites on alpha 1-acid glycoprotein. Pharmacogenetics; 403, 403-415.
  111. Enzyme induction. Edited by DV Parke. London: Plenum Press, 1975. 207-272.
  112. Breckenridge, A. M., Orme, M. L. E. (1971) Clinical implications of enzyme induction. Annals of the New York Academy of sciences; 179, 421-431. Go to original source... Go to PubMed...
  113. Corn, M. (1966) Effect of phenobarbital and glutethimide on biological half-life of warfarin. Thromb. Diath. Haemorrh; 16, 606. Go to PubMed...
  114. MacDonald, M. G., Robinson, D. S., Sylwester, D. et al. (1969) The effects of phenobarbital, chloral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responses in man. Clin. Pharmacol. Ther.; 10, 80-84. Go to PubMed...
  115. Massey, E. W. (1983) Effect of carbamazepine on coumadin metabolism. Ann. Neurol.; 13, 691-692. Go to original source... Go to PubMed...
  116. Cohen, S. N. and Armstrong, M. F. Drug Interactions. Baltimore MD: Williams & Wilkins, 1974.
  117. Kendall, A. G., Boivin, M. (1981) Warfarin-carbamazepine interaction. Ann. Intern. Med.; 94, 280. Go to original source...
  118. Hansen, J. M., Siersboek-Nielsen, K., Skovsted, L. (1971) Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clin. Pharmacol. Ther.; 12, 539-543. Go to PubMed...
  119. Taylor, J. W., Alexander, B., Lyon, L. W. (1980) Oral anticoagulant- phenytoin interactions. Drug Intell. Clin. Pharm.; 14, 669-673.
  120. Oakley, D. P., Lautch, H. (1963) Haloperidol and anticoagulant treatment. Lancet; 11, 1231. Go to original source...
  121. Udall, J. A. (1970) Drug interference with warfarin therapy. Clin. Med., 77, 20-25.
  122. Gould, L., Michael, A., Fisch, S. et al. (1972) Prothrombin levels maintained with meprobamate and warfarin. A controlled study. JAMA; 220, 1460-1462. Go to original source... Go to PubMed...
  123. Cullen, S. I., Catalano, P. M. (1967) Griseofulvin-warfarin antagonism. JAMA; 199, 582-583. Go to original source... Go to PubMed...
  124. Okino, K., Weibert, R. T. (1986) Warfarin-griseofulvin interaction. Drug Intell. Clin. Pharm.; 20, 291-293. Go to PubMed...
  125. Ohnhaus, E. E., Park, B. K. (1979) Measurement of urinary 6-ß-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. European Journal of Clinical Pharmacology; 15, 139-145. Go to original source... Go to PubMed...
  126. OReilly, R. A. (1974) Interaction of sodium warfarin and rifampicin. Annals of Internal Medicine; 81, 337-340. Go to original source... Go to PubMed...
  127. Davis, R. L., Berman, W. J., Wernly, J. A. et al. (1991) Warfarin- nafcillin interaction. J. Pediatr.; 118, 300-303. Go to original source... Go to PubMed...
  128. Mailloux, A. T., Gidal, B. E., Sorkness, C. A. (1996) Potential interaction between warfarin and dicloxacillin. Ann. Pharmacother.; 30, 1402-1407. Go to PubMed...
  129. Scher, M. L., Huntington, N. H., Vitillo, J. A. (1997) Potential interaction between tramadol and warfarin. Ann. Pharmacother.; 31, 646-647. Go to PubMed...
  130. Murray, R. M., Pitt, P., Jerums, G. (1981) Medical adrenalectomy with aminoglutethimide in the managment of advanced breast cancer. Med. J. Aust.; 1, 179-181. Go to PubMed...
  131. Bruning, P. F., Bonfrer, J. G. (1983) Aminoglutethimide and oral anticoagulant therapy. Lancet; 2, 582. Go to original source...
  132. Lonning, P. E., Kvinnsland, S., Jahren, G. (1984) Aminoglutethimide and warfarin. A new important drug interaction. Cancer. Chemother. Pharmacol.; 12, 10-12. Go to PubMed...
  133. Kvinssland, S., Lonning, P. E., Ueland, P. M. (1986) Aminoglutethimide as an inducer of microsomal enzymes. Part 1: Pharmacological aspects. Breast. Cancer Res. Treat.; 7(suppl.), S73-76.
  134. Cuddy, P. G., Loftus, L. S. (1986) Influence of mitotane on the hypoprothrombinemic effect of warfarin. South Med. J.; 79, 387-388. Go to original source... Go to PubMed...
  135. Desmond, P. V., Mashford, M. L., Harman, P. J. et al. (1984) Decreased oral warfarin clearance after ranitidine and cimetidine. Clin. Pharmacol. Ther.; 35, 338-341. Go to original source... Go to PubMed...
  136. Choonara, I. A. et al., (1986) Stereoselective interaction between the R enantiomer of warfarin and cimetidine. Br. J. Clin. Pharmacol.; 21, 271-277. Go to original source... Go to PubMed...
  137. Sax, M. J., Randolph, W. C., Peace, K. E. et al. (1987) Effect of two cimetidine regimens on prothrombin time and warfarin pharmacokinetics during long-term warfarin therapy. Clin. Pharm.; 6, 492-495. Go to PubMed...
  138. Toon, S., Hopkins, K. J., Garstan, F. M. et al. (1987) Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. Eur. J. Clin. Pharmacol.; 32, 165-172. Go to original source... Go to PubMed...
  139. Serlin, M. J., Sibeon, R. G., Breckenridge, A. M.(1981) Lack of effect of ranitidine on warfarin action. Br. J. Clin. Pharmacol.; 2, 791-794. Go to original source...
  140. Baciewicz, A. M., Morgan, P. J. (1990) Ranitidine-warfarin interaction. Ann. Intern. Med.; 112, 76-77. Go to original source...
  141. Lewis, J. H. (1986) Summary of the 30th Meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. Am. J. Gastroenterol.; 81, 495-498. Go to PubMed...
  142. De Lepeleire, I., Van Hecken, A., Verbesselt, R. et al. (1990) Lack of interaction between famotidine and warfarin. Int. J. Clin. Pharmacol. Res.; 10, 167-171.
  143. Cournot, A., Berlin, I., Sallord, J. C. et al. (1988) Lack of interaction between nizatidine and warfarin during chronic administration. J. Clin. Pharmacol.; 28, 1120-1122. Go to original source... Go to PubMed...
  144. Sutfin, T., Balmer, K., Bostrom, H. et al. (1989) Stereoselective interaction of omeprazole with warfarin in healthy men. Ther. Drug. Monit.; 11, 176-184. Go to original source... Go to PubMed...
  145. Duursema, L. et al. (1995) Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. Br. J. Clin. Pharmacol.; 39, 700-703. Go to original source... Go to PubMed...
  146. Heimark, L. D., Wienkers, L., Kunze, K. et al. (1992) The mechanism of the interaction between amiodarone and warfarin in humans. Clinical Pharmacology and Therapeutics; 51, 398-407. Go to original source... Go to PubMed...
  147. Kates, R. E., Yee, Y. G., Kirsten, E. B. (1987) Interaction between warfarin and propafenone in healthy volunteer subjects. Clin. Pharmacol. Ther.; 42, 305-311. Go to original source... Go to PubMed...
  148. Nenci, G. G., Agnelli, G., Berrentini, M. (1981) Biphasic sulphinpyrazone-warfarin interaction. British Medical Journal; 282, 1361-1362. Go to original source... Go to PubMed...
  149. Toon, S., Low, L. K., Gibaldi, M. et al. (1986) The warfarinsulfinpyrazone interaction: stereochemical considerations. Clin. Pharmacol. Ther.; 39, 15-24. Go to original source... Go to PubMed...
  150. Avery, G. S., (1973) Check-list of potential clinically important interactions. Drugs; 5, 187-211. Go to original source... Go to PubMed...
  151. Koch-Weser, J., Sellers, E. M. (1971) Drug interactions with coumarin anticoagulants. N. Engl. J. Med.; 285, 547-558. Go to original source... Go to PubMed...
  152. Pond, S. M., Graham, G. G., Wade, D. N. et al. (1975) The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man. Aust. N. Z. J. Med.; 5, 324-328. Go to original source...
  153. Rawlins, M. D., Smith, S. E. (1973) Influence of allopurinol on drug metabolism in man. Br. J. Pharmacol.; 48, 693-698. Go to original source... Go to PubMed...
  154. Vesell, E. S., Passananti, G. T., Greene, F. E. (1970) Impairment of drug metabolism in man by allopurinol and nortriptyline. N. Engl. J. Med.; 283, 1484-1488. Go to original source... Go to PubMed...
  155. Lewis, R. J. et al. (1974) Warfarin: stereochemical aspects of its metabolism and the interaction with phenylbutazone. Journal of Clinical Investigation; 53, 1607-1617. Go to original source... Go to PubMed...
  156. Powell-Jackson, P. R. (1977) Interaction between azapropazone and warfarin. Br. Med. J.; 1, 1193-1194. Go to original source...
  157. Green, A. E. et al. (1977) Potentiation of warfarin by azapropazone. Br. Med. J., 1; 1532. Go to original source...
  158. Win, N., Mitchell, D. C. (1991) Azapropazone and warfarin. Br. Med. J.; 302, 969-970. Go to original source...
  159. Chierichetti, S. et al. (1975) Comparison of fenprazone and phenylbutazone interaction with warfarin in man. Curr. Ther. Res.; 18, 568-572. Go to PubMed...
  160. Hylek, E. M., Heiman, H., Skates, S. et al. (1998) Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA; 279, 657-662. Go to original source... Go to PubMed...
  161. Jones, R. V. (1976) Warfarin and distalgesic interaction. Br. Med. J.; 1, 460. Go to original source...
  162. Boeijinga, J. J., Boerstra, E. E., Ris, P. et al. (1982) Interaction between paracetamol and coumarin anticoagulants. Lancet; 1, 506. Go to original source...
  163. Bartle, W. R., Blakely, J. A. (1991) Potentiation of warfarin anticoagulation by acetaminophen. JAMA; 265, 1260. Go to original source... Go to PubMed...
  164. Antlitz, A. M., Mead, J. A. Jr., Tolentino, M. A. (1968) Potentiation of oral anticoagulant therapy by acetaminophen. Curr. Therap. Res.; 10, 501-507.
  165. Shek, K. L. A., Chan, L. N., Nutescu, E. (1999) Warfarinacetaminophen drug interaction revisited. Pharmacotherapy; 19, 1153-1158. Go to original source... Go to PubMed...
  166. Orme, M., Breckenridge, A., Cook, P. (1976) Warfarin and distalgesic interaction. Br. Med. J.; 1, 200. Go to original source... Go to PubMed...
  167. Smith, R., Prudden, D., Hawkes, C. (1984) Propoxyphene and warfarin interaction. DICP; 18, 822.
  168. Justice, J. L., Kline, S. S. (1988) Analgesic and warfarin: a case that brings up the question and cautions. Postgrad. Med. J.; 83, 217-218.
  169. Yip, A. S. B., Chow, Y. T., Cheung, K. L. (1990) Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard. Postgrad. Med. J.; 66, 367-369. Go to original source... Go to PubMed...
  170. OReilly, R. A. (1980) Stereoselective interaction of trimethoprim- sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. N. Engl. J. Med.; 302, 33-35. Go to original source... Go to PubMed...
  171. Sioris, L. J., Weibert, R. T., Pentel, P. R. (1980) Potentiation of warfarin anticoagulation by sulfisoxazole. Arch. Intern. Med.; 140, 546-547. Go to original source... Go to PubMed...
  172. Lumholtz, B., Siersbaek-Nielsen, K., Skovsted, L. et al. (1975) Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism. Clin. Pharmacol. Ther.; 17, 731-734. Go to PubMed...
  173. Varma, D. L., Gupta, R. K., Gupta, S. (1975) Prothrombin response to phenindione during hypoalbuminemia. Br. J. Clin. Pharmacol.; 2, 467-468. Go to original source... Go to PubMed...
  174. Smith, A. G. (1984) Potentiation of oral anticoagulants by ketoconazole. Br. Med. J.; 288, 188-189. Go to original source...
  175. Watson, P. G., Lochan, R. G., Redding, V. J. (1982) Drug interactions with coumarin derivative anticoagulants. Br. Med. J.; 285, 1045-1046. Go to original source... Go to PubMed...
  176. Colquhoun, M. C., Daly, M., Stewart, P. et al. (1987) Interaction between warfarin and miconazole oral gel. Lancet; 1, 695-696. Go to original source...
  177. Ariyaratnam, S., Thakker, N. S., Sloan, P. et al. (1997) Potentiation of warfarin anticoagulant activity by miconazole oral gel. Br. Med. J.; 314, 349. Go to original source...
  178. Thirion, D. J. G., Farquhar Zanetti L. A.: Potentiation of warfarins hypoprothrombinemic effect with miconazole vaginal suppositories. Pharmacotherapy 2000; 20, 98-99. Go to original source... Go to PubMed...
  179. Black, D., Kunze, K., Wienkers, L. et al. (1996) Warfarinfluconazole: a metabolically based drug interaction: in vivo studies. Drug. Metab. Dispos.; 24, 422-428. Go to PubMed...
  180. Kerr, H. (1993) Case report: potentiation of warfarin by fluconazole. Am. J. Med. Sci.; 305, 164-165. Go to original source... Go to PubMed...
  181. Yeh, J., Soo, S. C., Summerton, C. et al. (1990) Potentiation of action of warfarin by itraconazole. Br. Med. J.; 301, 669. Go to original source...
  182. Toon, S., Hopkins, K. J., Garstang, F. M. et al. (1987) Enoxacinwarfarin interaction: pharmacokinetic and stereochemical aspects. Clin. Pharmacol. Ther.; 42, 33-41. Go to original source... Go to PubMed...
  183. Weibert, R. T., Lorentz, S. M., Townsend, R. J. et al. (1989) Effect of erythromycin in patients receiving long-term warfarin therapy. Clin. Pharm.; 8, 210-214. Go to PubMed...
  184. Lane, G. (1996) Increased hypothrombobinemic effect of warfarin possibly induced by azithromycin. Ann. Pharmacother.; 30, 884-885. Go to PubMed...
  185. Woldtvedt, B. R., Cahoon, C. L., Bradley, L. A. et al. (1998) Possible increased anticoagulation effect of warfarin induced by azithromycin. Ann. Pharmacother.; 32, 269-270. Go to original source...
  186. Recker, M. W., Kier, K. L. (1997) Potential interaction between clarithromycin and warfarin. Ann. Pharmacother.; 31, 996-998. Go to PubMed...
  187. Rosenthal, A. R., Self, T. H., Baker, E. D. et al. (1977) Interaction of isoniazid and warfarin. JAMA; 238, 2177. Go to original source... Go to PubMed...
  188. Bax, N. D., Lennard, M. S., Tucker, G. T. et al. (1984) The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose. Br. J. Clin. Pharmacol.; 17, 553-557. Go to original source... Go to PubMed...
  189. Kramer, P., Tsuru, M., Cook, C. E. et al. (1984) Effect of influenza vaccine on warfarin anticoagulation. Clin. Pharmacol. Ther.; 35, 416-418. Go to original source... Go to PubMed...
  190. Lipsky, B. A., Pecoraro, R. E., Roben, N. J. et al. (1984) Influenza vaccination and warfarin anticoagulation. Ann. Intern. Med.; 100, 835-837. Go to original source... Go to PubMed...
  191. Gomolin, I. H., Chapron, D. J., Luhan, P. A. (1985) Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J. Am.Geriatr. Soc.; 33, 269-272. Go to original source... Go to PubMed...
  192. Gomolin, I. H. (1986) Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly. Can. Med. Assoc. J.; 135, 39-41.
  193. Adachi, Y. et al. (1995) Potentiation of warfarin by interferon. Br. Med. J.; 311, 292. Go to original source...
  194. Darlington, M. R. (1997) Hypoprothrombinemia during concomitant therapy with warfarin and saquinavir. Ann. Pharmacother.; 31, 647.
  195. Rothstein, E. (1968) Warfarin effect enhanced by disulfiram. JAMA; 206, 1574-1575. Go to original source...
  196. Rothstein, E. (1972) Warfarin effect enhanced by disulfiram (Antabuse). JAMA; 221, 1052-1053. Go to original source...
  197. OReilly, R. A. (1973) Interaction of sodium warfarin and disulfiram (Antabuse) in man. Ann. Intern. Med.; 78, 73. Go to original source... Go to PubMed...
  198. OReilly, R. A. (1981) Dynamic interaction between disulfiram and separated enantiomorphs of racemic warfarin. Clin. Pharmacol. Ther.; 29, 332-336. Go to original source... Go to PubMed...
  199. Wajima, T., Mukhopadhyay, P. (1992) Possible interactions between warfarin and 5-fluorouracil. Am. J. Hematol.; 40, 238. Go to original source...
  200. Scarfe, M. A., Israel, M. K. (1994) Possible drug interaction between warfarin and combination of levamisole and fluorouracil. Ann. Pharmacother.; 28, 464-467. Go to PubMed...
  201. Chlebowski, R. T., Gota, Ch., Chan, K. K. et al. (1982) Clinical and pharmacokinetic effects of combined warfarin and 5- fluorouracil in advanced colon cancer. Cancer Res.; 42, 4827-4830. Go to PubMed...
  202. Brown, M. C. (1999) An adverse interaction between warfarin and 5-fluorouracil: a case report and review of the literature. Chemotherapy; 45, 392-395. Go to original source... Go to PubMed...
  203. Aki, Z., Kotiloglu, G., Ozyilkan, O. (2000) A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin. Am. J. Gastroenterol.; 95, 1093-1094. Go to original source... Go to PubMed...
  204. Vesell, E. S., Passananti, G. T., Greene, F. E. (1970) Impairment of drug metabolism in man by allopurinol and nortriptyline. N. Engl. J. Med.; 283, 1484-1488. Go to original source... Go to PubMed...
  205. Williams, J. R., Griffin, J. P., Parkins, A. (1976) Effect of concomitantly administered drugs on the control of long term anticoagulant therapy. Q. J. Med., 45, 63-73. Go to PubMed...
  206. Pond, S. M., Graham, G. G., Birkett, D. J. et al. (1975) Effects of tricyclic antidepressants on drug metabolism. Clin. Pharmacol. Ther.; 18, 191-199. Go to PubMed...
  207. Benfield, P., Ward, A. (1986) Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs; 32, 313-334. Go to original source... Go to PubMed...
  208. Dent, L. A., Orrock, M. W. (1997) Warfarin-fluoxetine and diazepam-fluoxetine interaction. Pharmacotherapy; 17, 170-172. Go to PubMed...
  209. Ahmad, S. (1990) Gemfibrozil interaction with warfarin sodium (Coumadin). Chest; 98, 1041-1042. Go to original source...
  210. Ahmad, S. (1190) Lovastatin: warfarin interaction. Arch. Intern. Med.; 150, 2407.
  211. Kline, S. S., Harrell, C. C. (1997) Potential warfarin-fluvastatin interaction. Ann. Pharmacother.; 31, 790.
  212. Grau, E. et al. (1996) Simvastatin-oral anticoagulant interaction. Lancet; 347, 405-406. Go to original source...
  213. Gaw, A., Wosornu, D. (1992) Simvastatin during warfarin therapy in hyperlipoproteinaemia. Lancet; 340, 979-980. Go to original source...
  214. Trenque, T. et al. (1996) Pravastatin: interaction with oral anticoagulant? Br. Med. J.; 312, 886.
  215. Cropp, J. S., Bussey, H. I. (1997) A review of enzyme induction of warfarin metabolism with recommendations for patient management. Pharmacotherapy; 17, 917-928. Go to PubMed...
  216. Chatterjea, J. B., Salomon, L. (1954) Antagonistic effect of ACTH and cortisone on the anticoagulant activity of ethyl biscoumacetate; 2, 790-792.
  217. Kalowski, S., Kincaid-Smith, P. (1973) Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis. Med. J. Aust.; 2, 164-166 Go to PubMed...
  218. Mott, F. E., Murphy, S., Hunt, V. (1989) Ciprofloxacin and warfarin. Ann. Intern. Med.; 3, 542-543. Go to original source...
  219. Kamada, A. K. (1990) Possible interaction between ciprofloxacin and warfarin. DICP; 24, 27-28. Go to PubMed...
  220. Johnson, K. C., Joe, R. H., Self, T. H. (1991) Drug Interaction. J. Fam. Pract.; 33, 338. Go to PubMed...
  221. Dugoni-Kramer, B. M. (1991) Ciprofloxacin-warfarin interaction. DICP; 25, 1397.
  222. Linville, D., Emory, C., Graves, L. (1991) Ciprofloxacin and warfarin interaction. Am. J. Med.; 90, 765. Go to original source...
  223. Jolson, H. M., Tanner, L. A., Green, L. et al. (1991) Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Arch. Intern. Med.; 151,1003-1004. Go to original source... Go to PubMed...
  224. Linville, T., Matanin, D. (1989) Norfloxacin and warfarin. Ann. Intern. Med.; 110, 751-752. Go to original source...
  225. Leor, J., Matetzki, S. (1988) Ofloxacin and warfarin. Ann. Intern. Med.; 109, 761. Go to original source...
  226. Baciewicz, A. M., Ashar, B. Y., Locke, T. W. (1993) Interaction of ofloxacin and warfarin. Ann. Intern. Med.; 119, 1223. Go to original source...
  227. Ellis, R. J., Mayo, M. S., Bodensteiner, D. M. (2000) Ciprofloxacin- warfarin coagulopathy: a case series. Am. J. Hematol.; 63, 28-31. Go to original source... Go to PubMed...
  228. Armstrong, G. et al. (1991) Warfarin potentiated by proguanil. Br. Med. J.; 303, 789.
  229. Ostlere, L. S., Langtry, J. A., Jones, S. et al. (1991) Reduced therapeutic effect of warfarin caused by etretinate. Br. J. Dermatol.; 124, 505. Go to original source...
  230. Scher, M. L., Huntington, N. H., Vitillo, J. A. (1997) Potential interaction between tramadol and warfarin. Ann. Pharmacother.; 31, 646-647. Go to PubMed...
  231. Sabbe, J. R., Sims, P. J., Sims, M. H. (1998) Tramadol-warfarin interaction. Pharmacotherapy; 18, 871-873. Go to PubMed...
  232. Ward, K., Bitran, J. D. (1984) Warfarin, etoposide, and vindesine interactions. Cancer Treat. Rep.; 68, 817. Go to PubMed...
  233. Le, A. T. et al. (1997) Enhacement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy. Ann. Pharmacother.; 31, 1006-1008. Go to PubMed...
  234. Hall, G., Lind, M. J., Huang, M. et al. (1990) Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control. Postgrad. Med. J.; 66, 860-861. Go to original source... Go to PubMed...
  235. Lodwick, R., McConkey, B., Brown, A. M. (1987) Life threatening interaction between tamoxifen and warfarin. Br. Med. J.; 295, 1141. Go to original source...
  236. Tenni, P., Lalich, D. L., Byrne, M. J. (1989) Life threatening interaction between tamoxifen and warfarin. Br. Med. J.; 298, 93-94. Go to original source...
  237. Ritchie, L. D., Grant, S. M. T. (1989) Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file. Br. Med. J.; 298, 1253. Go to original source...
  238. Turri, D., Iannitto, E., Caracciolo, C. et al. (2000) Oral anticoagulants and cyclosporin. A. Haematologica; 85, 893-894. Go to PubMed...
  239. Snyder, D. S. (1988) Interaction between cyclosporine and warfarin. Ann. Intern. Med.; 108, 311. Go to original source...
  240. Serpa, M. D., Cossolias, J., McGreevy, M. J. (1992) Moricizinewarfarin: a possible drug interaction. Ann. Pharmacother.; 26, 127.
  241. Zimmermann, R. et al. (1988) The effect bezafibrate on the fibrinolytic enzyme system and the drug interaction with racemic phenprocoumon. Atherosclerosis; 74, 247-249. Go to PubMed...
  242. Ascah, K. J., Rock, G. A., Wells, P. S. (1988) Interaction between fenofibrate and warfarin. Ann. Pharmacother.; 32, 765-768. Go to original source...
  243. Pan, H. Y. M., Ng, R. P. (1983) The effect of Nootropil in a patient on warfarin. Eur. J. Clin. Pharmacol.; 24, 711. Go to original source... Go to PubMed...
  244. Rosenthal, G. (1971) Interaction of ascorbic acid and warfarin. JAMA; 215, 1671. Go to original source...
  245. Smith, E. C., Skalski, R. J., Johnson, G. C. et al. (1972) Interaction of ascorbic acid and warfarin. JAMA; 221, 166. Go to original source...
  246. Anon (1985) Vitamin supplements. Med. Lett. Drugs Ther.; 27, 66-68. Go to PubMed...
  247. Corrigan, J. J., Marcus, F. I. (1974) Coagulopathy associated with vitamin E ingestion. JAMA; 230, 1300. Go to original source... Go to PubMed...
  248. Tùmová, L. (2000) Interactions between medicinal plants and drugs. Czech and Slovak Pharmacy; 49, 162-167. Go to PubMed...
  249. Makheja, A. N., Bailey, J. M. (1982) A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium). Prostagl. Leukotr. Med.; 8, 653-660.
  250. Makheja, A. N., Bailey, J. M. (1981) The active principle in feverfew. Lancet; 2, 1054. Go to original source...
  251. Kiesewetter, H., Jung, F., Jung, E. M. et al. (1993) Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischemia attack. Eur. J. Clin. Pharmacol; 45, 333-336. Go to original source... Go to PubMed...
  252. Kiesewetter, H., Jung, F., Jung, E. M. et al. (1993) Effects of garlic coated tablets in peripheral arterial occlusive disease. Clin. Invest., 71, 383-386. Go to original source... Go to PubMed...
  253. German, K., Kumar, U., Blackford, H. N. (1995) Garlic and the risk of TURP bleeding. Br. J. Urol.; 76, 518. Go to original source... Go to PubMed...
  254. Lumb, A. B. (1994) Effect of dried ginger on human platelet function. Thromb. Hemostasis; 71, 110-111.
  255. Rowin, J., Lewis, S. L. (1996) Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology; 46, 1775-1776. Go to original source... Go to PubMed...
  256. Lewis, S. L., Rowin, J. (1997) Ginkgo biloba. Neurology; 48, 1137. Go to original source...
  257. Kuo, S. C., Teng, C. M., Lee, J. C. et al. (1990) Antiplatelet components in Panax ginseng. Planta Med., 56, 164-167. Go to original source... Go to PubMed...
  258. Matsuda, H., Namba, K., Fukuda, S. et al. (1986) Pharmacological Study on Panax ginseng C.A. Meyer. III. Effects of red ginseng on experimental disseminated intravascular coagulation. (2). Effects of ginsenosides on blood coagulative and fibrinolytic systems. Chem. Pharm. Bull.; 34, 1153-1157. Go to original source... Go to PubMed...
  259. Nebel, A., Schneider, B. J., Baker, R. K. et al. (1999) Potential metabolic interaction between St. Johns Wort and theophylline. Ann. Pharmacotherapy; 33, 502. Go to original source... Go to PubMed...
  260. Yue, Q. Y., Bergquist, C., Gerden, B. (2000) Safety of St. Johns Wort. Lancet; 355, 576-577. Go to original source...
  261. Lambert, J. P., Cormier, J. (2001) Potential interation between warfarin and boldo-fenugreek. Pharmacotherapy; 21, 509-512. Go to original source... Go to PubMed...
  262. Musa, M. N., Lyons, L. L. (1976) Absorption and disposition of warfarin: effects of food and liquids. Curr. Ther. Res.; 20, 630.
  263. Blickstein, D., Shaklai, M., Inbal, A. (1991) Warfarin antagonism by avocado. Lancet; 337, 914-915. Go to original source...
  264. Simon, L. S., Likes, K. E. (1978) Hypoprothrombinemic response due to ice cream. Drug Intell. Clin. Pharm.; 12, 121-122.
  265. Karlson, B., Leijd, B., Hellstrom, K. (1986) On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta. Med. Scand.; 220, 347-350. Go to original source... Go to PubMed...
  266. Kudo, T. (1990) Warfarin antagonism of NATTO and increase in serum vitamin K by intake of NATTO. Artery; 17, 189-201. Go to PubMed...
  267. Sullivan, D. M., Ford, M. A., Boyden, T. W. (1998) Grapefruit juice and the response to warfarin. Am. J. Health. Syst. Pharm.; 55, 1581-1583. Go to PubMed...
  268. Kater, R. M., Roggin, G., Tobon, F. et al. (1969) Increased rate of clearance of drugs from the circulation of alcoholics. Am. J. Med. Sci., 258, 35-39. Go to original source... Go to PubMed...
  269. HW Colvin, J. R., Lee Wang, W. (1974) Toxic effects of warfarin in rats fed different diets. Toxicology and Applied Pharmacology; 28, 337-348. Go to original source... Go to PubMed...
  270. Barder, D. L, HW Colvin, J. R. (1980) Influence of dietary protein on the response of rats receiving toxic levels of warfarin. Toxicology and Applied Pharmacology; 56, 8-15. Go to original source... Go to PubMed...

Return to the content